EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSOMYG00000010634
Gene Symbol: PTGS2B
1 Cross references
203 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSOMYG00000009717
Gene Symbol: PTGS2B
1 Cross references
202 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOMYG00000038560
Gene Symbol: PSMA1
2 Cross references
199 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOMYG00000028568
Gene Symbol: PSMA1
1 Cross references
204 Possible Orthologues:

Proteasome 20s Subunit Alpha 2b

Ensembl ID : ENSOMYG00000034739
Gene Symbol: PSMA2B
1 Cross references
267 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSOMYG00000019274
Gene Symbol: PSMA3
1 Cross references
232 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSOMYG00000036901
Gene Symbol: PSMA3
1 Cross references
233 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSOMYG00000024164
Gene Symbol: PSMA4
2 Cross references
166 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSOMYG00000029450
Gene Symbol: PSMA5
1 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSOMYG00000047309
Gene Symbol: PSMA6
1 Cross references
265 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSOMYG00000037281
Gene Symbol: PSMA8
1 Cross references
166 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSOMYG00000027172
Gene Symbol: PSMA8
1 Cross references
131 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).